Clinical Trial Update: Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial compares the effects of recombinant human growth hormone (somatropin) versus recombinant human IGF-1 (mecasermin) on cardiovascular risk fa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Somatropin (somatropin)
• mecasermin (insulin-like growth factor 1)

Snippet

Sponsor: Columbia University | Conditions: Growth Hormone Deficiency | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-07-17